×
Entrez Id:
596
Gene Symbol:
BCL2
BCL2
0.310
Biomarker
disease
BEFREE
After restaining, 9 cases proved to be truly BCL-2 negative (6 follicular lymphoma grade 2 , 2 follicular lymphoma grade 3a, and 1 follicular lymphoma grade 3b).
21855110
2012
×
Entrez Id:
596
Gene Symbol:
BCL2
BCL2
0.310
Biomarker
disease
CTD_human
High molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyclophosphamide-vincristine-prednisone plus interferon alpha 2b.
12855623
2003
×
Entrez Id:
596
Gene Symbol:
BCL2
BCL2
0.310
Biomarker
disease
CTD_human
Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation.
3287162
1988
ATP6V1B2
0.300
Biomarker
disease
CTD_human
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
26691987
2016
×
Entrez Id:
64121
Gene Symbol:
RRAGC
RRAGC
0.300
Biomarker
disease
CTD_human
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
26691987
2016
×
Entrez Id:
537
Gene Symbol:
ATP6AP1
ATP6AP1
0.300
Biomarker
disease
CTD_human
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
26691987
2016
×
Entrez Id:
2531
Gene Symbol:
KDSR
KDSR
0.300
Biomarker
disease
CTD_human
Towards a systematic analysis of human short-chain dehydrogenases/reductases (SDR): Ligand identification and structure-activity relationships.
25526675
2015
×
Entrez Id:
1387
Gene Symbol:
CREBBP
CREBBP
0.300
Biomarker
disease
CTD_human
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
24362818
2014
×
Entrez Id:
7128
Gene Symbol:
TNFAIP3
TNFAIP3
0.300
Biomarker
disease
CTD_human
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
24362818
2014
×
Entrez Id:
2146
Gene Symbol:
EZH2
EZH2
0.300
Biomarker
disease
CTD_human
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
24362818
2014
×
Entrez Id:
4615
Gene Symbol:
MYD88
MYD88
0.300
Biomarker
disease
CTD_human
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
24362818
2014
×
Entrez Id:
1879
Gene Symbol:
EBF1
EBF1
0.300
Biomarker
disease
CTD_human
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
24362818
2014
×
Entrez Id:
8085
Gene Symbol:
KMT2D
KMT2D
0.300
Biomarker
disease
CTD_human
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
24362818
2014
×
Entrez Id:
4548
Gene Symbol:
MTR
MTR
0.300
Biomarker
disease
CTD_human
Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas.
16410450
2006
×
Entrez Id:
4524
Gene Symbol:
MTHFR
MTHFR
0.300
Biomarker
disease
CTD_human
Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas.
16410450
2006
×
Entrez Id:
7298
Gene Symbol:
TYMS
TYMS
0.300
Biomarker
disease
CTD_human
Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas.
16410450
2006
×
Entrez Id:
3440
Gene Symbol:
IFNA2
IFNA2
0.300
Therapeutic
disease
CTD_human
High molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyclophosphamide-vincristine-prednisone plus interferon alpha 2b.
12855623
2003